Data Bridge Market Research analyses that the analgesics market was valued at USD 49.02 billion in 2021 and is expected to reach USD 70.73 billion by 2029, registering a CAGR of 4.69% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient…

Data Bridge Market Research analyses that the viral hepatitis market was valued at USD 14.98 billion in 2021 and is expected to reach USD 19.73 billion by 2029, registering a CAGR of 3.50% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient…

Data Bridge Market Research analyses that the neuromyelitis optica spectrum disorder (NMOSD) market was valued at USD 405.9 million in 2021 and is expected to reach USD 651.84 million by 2029, registering a CAGR of 6.10% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes…

Data Bridge Market Research analyses that the Canada hemodialysis and peritoneal dialysis market which is USD 970.48 million in 2022, is expected to reach USD 1523.62 million by 2030, at a CAGR of 5.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient…

Europe Neuroendocrine Tumors Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.2% in the forecast period of 2021 to 2028 and is expected to reach USD 1,153.85 million by 2028. Increased incidence of neuroendocrine tumor cases is acting as a driver for the neuroendocrine tumors market.

The initiation of tumor takes place when the DNA of healthy cells is damaged which causes…

Melioidosis treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5% in the above mentioned forecast period.

Melioidosis is an infectious disease which is caused by the facultative intracellular gram-negative bacterium, Burkholderia pseudomallei which exist in both soil and water. This disorder is also known as Whitmore disease, Rangoon beggar’s disease or Vietnamese…

Banti’s syndrome treatment market is expected to gain market growth at a potential rate of 4.60% in the forecast period of 2021 to 2028. Rise in the well-defined reimbursement policies from public and private health insurance is the vital factor escalating the market growth.

Banti syndrome is defined as a disorder of the spleen, the large, gland-like organ in the upper left side of the abdomen that produces red blood cells before birth and, in new born, removes and destroys aged red…

Global allogeneic human chondrocyte market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 11.1% in the above mentioned forecast period.

Allogeneic human chondrocyte is an emerging therapy which is used to repair cartilage and other indications. This therapy is anticipated to be a good alternative to autologous chondrocyte implantation in the near future. Cartilage restoration…

The hesperedin market is expected to witness market growth at a rate of 5.30% in the forecast period of 2021 to 2028. Data Bridge Market Research report on hesperedin market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the awareness globally is escalating the growth of hesperedin market.

Hesperidin refers to bioflavonoid glycoside which is mostly…

Asia-Pacific intraoperative radiation therapy market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market is growing with a CAGR of 7.0% in the forecast period of 2021 to 2028 and is expected to reach USD 89.91 million by 2028. Increasing demand for intraoperative radiation therapy in medical industry is a major driver for the Asia-Pacific intraoperative radiation therapy market.

Intraoperative Radiotherapy…

The North America neuroendocrine tumors market is expected to gain market growth in the forecast period of 2020 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.3% in the forecast period of 2021 to 2028 and is expected to reach USD 2,679.49 million by 2028. Increased incidence of neuroendocrine tumor cases is acting as a driver for the neuroendocrine tumors market.

The initiation of tumor takes place when the DNA of healthy cells is damaged…

Angle-closure glaucoma market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Rising prevalence of eye related disorders worldwide and emerging markets are the factors responsible for the growth of this market.

Growing cases of glaucoma drives the angle-closure glaucoma market. Due to family history of eye diseases, presence of…

The global expectorants market is expected to witness significant growth during the forecast period. Growing cases of dry cough which causes dryness in the throat drives the expectorants market. However, easy availability of expectorants OTC drugs and rising respiratory disease prevalence will boost the expectorants market. Medical advancements which involves ongoing drug discovery, and government and non-government organizational initiatives are what that boosts the market growth. COVID-19…

The global cephalosporin market is expected to witness significant growth during the forecast period. The factors driving this market's growth are emerging markets and massive investment in research and development. The growth of the cephalosporin market enhanced by the growing cases of respiratory tract infections and increase research and development activities. Furthermore, advancements in treatment options and the presence of well-established healthcare facilities are some of the factors…

Data Bridge Market Research analyses a growth rate in the global antidotes market in the forecast period 2022-2029. The expected CAGR of global antidotes market is tend to be around 9.0% in the mentioned forecast period. The market was valued at USD 1.74 billion in 2021, and it would grow upto USD 3.47 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by…

Data Bridge Market Research analyses a growth rate in the global hematuria treatment market in the forecast period 2022-2029. The expected CAGR of global hematuria treatment market is tend to be around 2.90% in the mentioned forecast period. The market was valued at USD 932.89 million in 2021, and it would grow upto USD 1172.61 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario,…

The global uterotonic agent market is expected to witness significant growth during the forecast period. The market is majorly driven by rising cases of abortion and the vulnerable women population. In addition, advances in biotechnological and pharmaceuticals sectors or industries and more collaborations are some impacting factors driving market growth. Among the different types, oxytocin is one such drug that is widely used for lactation and parturition among others.

Data Bridge…

The global congestive renal failure (CRF) market is expected to witness significant growth during the forecast period. Factors such as gross domestic product (GDP) and the increasing inflation rate are expected to affect the CRF market's development. Growing prevalence of kidney failure worldwide and evolving markets are the factors responsible for the growth of this market. COVID-19 also had a major impact on the congestive renal failure (CRF) market.

Data Bridge Market Research…

Colombia gastric cancer drugs market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyzes that the market is growing with a CAGR of 8.5% in the forecast period of 2022 to 2029 and is expected to reach USD 47.73 million by 2029. Rising cases of gastrointestinal tumors, lymphoma and adenocarcinoma have increased the demand for medication and treatment, which is expected to drive the growth of the gastric cancer drugs…

Asia-Pacific Neuroendocrine Tumors market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.5% in the forecast period of 2021 to 2028 and is expected to reach USD 929.49 million by 2028. Strategic initiatives by market players and advent of mass vaccination programmes for neuroendocrine tumors are likely to be the major drivers which propelled the demand of the market in the forecast…